IDR Data
CMS PUF data · 2023 Q1–2025 Q4

CPT 36556: Federal IDR outcomes

Insertion of non-tunneled central venous tube for infusion (5 years or older)

In 2025 Q1–Q4, the provider or facility offer prevailed in 89.9% of 446 determined Federal IDR dispute line items for CPT 36556. The median prevailing offer was 4.51x the QPA (25th–75th percentile 2.35x–7.56x; n = 411). The median time to a decision was 32 business days (n = 446).

Determined line items

446

2025 Q1–Q4 · 0 split decisions excluded

Provider win rate

89.9%

n = 446 · 2025 Q1–Q4

Median payment vs QPA

4.51x

middle half 2.35x–7.56x · n = 411 · 2025 Q1–Q4

Median days to decision

32

business days, from dispute initiation · n = 446 · 2025 Q1–Q4

Dollar amounts

Total awarded

$77,300

sum of prevailing offers · n = 93 · 2025 Q1–Q4

Total QPA

$25,716

sum of QPAs, same line items · n = 93 · 2025 Q1–Q4

Awarded above QPA

$51,584

total awarded minus total QPA · n = 93 · 2025 Q1–Q4

Median award per line item

$599

mean $831 · n = 93 · 2025 Q1–Q4

Median QPA

$141

per line item · n = 93 · 2025 Q1–Q4

Award vs QPA, dollar-weighted

3.01x

total awarded ÷ total QPA · n = 93 · 2025 Q1–Q4

Dollar amounts come from the separate CMS “QPA and Offers” file: line items decided for the provider or the plan with a non-suppressed QPA and prevailing offer. That file cannot be joined to the line items above, so its n differs. Awarded = the prevailing (selected) offer; it is not a record of what was paid. State comes from the file’s geographic region; a metro area that spans states counts in each. How the dollar figures work

Dollar amounts by period

PeriodLine items with $Total awardedTotal QPAAbove QPAMedian awardMedian QPAAward ×QPA ($-weighted)
2025 Q1–Q493$77,300$25,716$51,584$599$1413.01x
2024 Q3–Q437$40,480$5,953$34,527$1,071$1526.80x
2024 Q3–2025 Q4130$117,779$31,669$86,111$614$1413.72x
2023 Q1–2024 Q2Not available (see methodology).

From the CMS QPA and Offers file (see above). Award ×QPA here is total awarded ÷ total QPA, so large claims weigh more than in the per-line median ratio.

By period

PeriodLine itemsWin %Median ×QPA25th–75thRatio nMedian days
2025 Q1–Q444689.9%4.51x2.35x–7.56x41132
2024 Q1–Q420781.6%4.36x1.94x–8.20x16683
2023 Q1–Q47075.7%2.83x1.00x–7.56x4971
2023 Q1–2025 Q472386.2%4.50x2.14x–7.62x626not pooled

Line items = determined dispute line items (n). Win rate excludes split decisions and includes default decisions. Ratio n = line items reporting a payment-to-QPA ratio. Days are business days as reported by CMS (2023–2024: from IDR entity assignment; 2025: from initiation) and are never pooled.

By state

State (place of service)Line itemsWin %Median ×QPARatio nMedian days
Texas10289.2%5.93x8933.5
Arizona6288.7%2.46x5939.5
California4185.4%4.88x3936
Florida3697.2%2.26x3227

2025 Q1–Q4 · rows with n ≥ 30 determined line items · sorted by n.

By specialty

Specialty groupLine itemsWin %Median ×QPARatio nMedian days
Emergency medicine and emergency departments13793.4%4.59x11133
Radiology9094.4%5.52x9024
Anesthesiology8483.3%3.73x8033.5
Internal and family medicine6888.2%5.02x6750

2025 Q1–Q4 · rows with n ≥ 30 determined line items · sorted by n.

Section: Surgery (10004–69990)

FAQ

What is the Federal IDR provider win rate for CPT 36556?

In 2025 Q1–Q4, the provider or facility offer was selected in 89.9% of 446 determined dispute line items for CPT 36556. Split decisions are excluded from the denominator and default decisions are included. Withdrawn, settled and ineligible disputes are not in the CMS data.

How do Federal IDR payments compare with the QPA for CPT 36556?

In 2025 Q1–Q4, the median prevailing offer was 4.51x the qualifying payment amount (QPA), with a 25th to 75th percentile range of 2.35x to 7.56x (n = 411 line items). This uses the CMS field Prevailing Party Offer as % of QPA, where 1.00x equals the QPA.

How long do Federal IDR decisions take for CPT 36556?

In 2025 Q1–Q4, the median was 32 business days (n = 446 line items), using the CMS field Length of Time to Make Determination (from dispute initiation).

How to Utilize IDR